Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study
Drug Design, Development and Therapy · 2026-07 · Volume 20 · 1-13
DOI: 10.2147/dddt.s607574 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-07. Verfasst von Honghan Qiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China. Hauptthemen laut MEDLINE: Brentuximab Vedotin, Lymphoma, Antineoplastic Agents, Immunological. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China.
- Department of Hematology, Henan Cancer Hospital, Zhengzhou, 450008, People's Republic of China.
- Department of Hematology, Zhengzhou University People's Hospital and Henan Provincial People's Hospital, Zhengzhou, 450003, People's Republic of China.
ORCID-Profile: Honghan Qiao, Xingchen Liu, Huijie Nan
Zitieren
APA
Qiao, H., Liu, X., Nan, H., Zhang, M., Bai, Y., Zhou, K., & Zhang, X. (2026). Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study. Drug Design, Development and Therapy, Volume 20, 1-13. https://doi.org/10.2147/dddt.s607574
Vancouver
Qiao H, Liu X, Nan H, Zhang M, Bai Y, Zhou K, et al. Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study. Drug Design, Development and Therapy. 2026;Volume 20:1-13. doi:10.2147/dddt.s607574
BibTeX
@article{Qiao2026,
author = {Qiao, Honghan and Liu, Xingchen and Nan, Huijie and Zhang, Mingzhi and Bai, Yanliang and Zhou, Keshu and Zhang, Xudong},
title = {Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--13},
doi = {10.2147/dddt.s607574}
}
EUVIMED